Emergent BioSolutions (EBS) Soars: Stock Rises 8.6% - Tale of the Tape

Emergent BioSolutions, Inc. (EBS) was a big mover last session, as its shares rose nearly 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare company, as the stock is now trading above the volatile price range of $24.42 to $25.66 in the past one-month timeframe.

In the last 30 days, the company witnessed one positive estimate revision while the Zacks Consensus Estimate moved lower. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Emergent BioSolutions currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Cambrex Corporation (CBM), Alkermes plc (ALKS) and Biogen Idec Inc. (BIIB). While Biogen Idec and Alkermes sport a Zacks Rank #1 (Strong Buy), Cambrex carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

ALKERMES INC (ALKS): Free Stock Analysis Report

BIOGEN IDEC INC (BIIB): Free Stock Analysis Report

EMERGENT BIOSOL (EBS): Free Stock Analysis Report

PRO-SH BAS MATL (SBM): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research